Position in ABBV
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,001,527
New position
Shares Held
3,980
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#2,545
of 4,167 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SEIZERT CAPITAL PARTNERS, LLC holds $92,983,054 across 6 Drug Manufacturers - General names. ABBV ranks #5 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
162,741 | $41,331,331 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
667,883 | $38,483,418 | |
| 3 | AMGN |
Amgen Inc
|
18,902 | $6,844,792 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
37,822 | $4,778,431 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
3,980 | $1,001,527 | |
| 6 | MRK |
Merck & Co., Inc.
|
4,230 | $543,555 |
All Filings in ABBV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,001,527 | 3,980 | Shares | Sole | 2026-08-05 | |
| No filing history on record for this holder in this stock. | ||||||